Page last updated: 2024-09-03

sb 204070a and purpurin

sb 204070a has been researched along with purpurin in 1 studies

Compound Research Comparison

Studies
(sb 204070a)
Trials
(sb 204070a)
Recent Studies (post-2010)
(sb 204070a)
Studies
(purpurin)
Trials
(purpurin)
Recent Studies (post-2010) (purpurin)
450419012

Protein Interaction Comparison

ProteinTaxonomysb 204070a (IC50)purpurin (IC50)
Female germline-specific tumor suppressor gld-1Caenorhabditis elegans6.688
Cytochrome P450 1A1Homo sapiens (human)5.5
Amine oxidase [flavin-containing] AHomo sapiens (human)3.8725
Cytochrome P450 1B1Homo sapiens (human)2.2
Thiosulfate sulfurtransferaseHomo sapiens (human)2.3
60 kDa chaperonin Escherichia coli4
10 kDa chaperonin Escherichia coli4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A1

Other Studies

1 other study(ies) available for sb 204070a and purpurin

ArticleYear
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
    Bioorganic & medicinal chemistry letters, 2019, 05-01, Volume: 29, Issue:9

    Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin

2019